Controlled Substances Market

Controlled Substances Market Analysis by Opioids, Stimulants, Depressants, and Marijuana for ADHD, Pain Management, Depression, Seizures, and Anxiety from 2023 to 2033

By Fact.MR Healthcare Desk Fact-checked under the Fact.MR editorial process Updated 14 min read

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Key Success Factors
  • 5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
  • 6. Market Background
  • 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Drug Class
    • 7.1. Opioids
      • 7.1.1. Codeine
      • 7.1.2. Morphine
      • 7.1.3. Fentanyl
      • 7.1.4. Meperidine
      • 7.1.5. Methadone
      • 7.1.6. Oxycodone
      • 7.1.7. Others
    • 7.2. Stimulants
      • 7.2.1. Amphetamine
      • 7.2.2. Methylphenidate
      • 7.2.3. Dextroamphetamine
      • 7.2.4. Methamphetamine
      • 7.2.5. Others
    • 7.3. Depressants
      • 7.3.1. Barbiturates
      • 7.3.2. Benzodiazepines
    • 7.4. Marijuana
      • 7.4.1. Medical Marijuana
      • 7.4.2. Recreational Marijuana
  • 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application
    • 8.1. Attention-Deficit/Hyperactivity Disorder (ADHD)
    • 8.2. Pain Management
    • 8.3. Depression
    • 8.4. Seizure
    • 8.5. Anxiety
    • 8.6. Sleep Disorders
    • 8.7. Cough Suppression
    • 8.8. Others
  • 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
    • 9.1. Institutional Sale
      • 9.1.1. Hospitals
      • 9.1.2. Clinics
      • 9.1.3. Rehabilitation Centers
    • 9.2. Retail Sales
      • 9.2.1. Retail Pharmacies
      • 9.2.2. E-Commerce/Mail Order Pharmacies
  • 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
    • 10.1. North America
    • 10.2. Latin America
    • 10.3. Europe
    • 10.4. Middle East and Africa (MEA)
    • 10.5. East Asia
    • 10.6. South Asia
    • 10.7. Oceania
  • 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 14. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 18. Emerging Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
  • 19. Competition Analysis
    • 19.1. Cambrex
    • 19.2. Patheon
    • 19.3. Consort Medical
    • 19.4. Cayman Chemical
    • 19.5. AMRI
    • 19.6. Siegfried AG
    • 19.7. Johnson Matthey
    • 19.8. SAFC/Cerilliant
    • 19.9. Noramco, Inc
    • 19.10. Mallinckrodt plc
    • 19.11. GlaxoSmithKline plc.
    • 19.12. Purdue Pharma L.P.
    • 19.13. Teva Pharmaceuticals, Inc.
    • 19.14. Johnson & Johnson (Janssen)
    • 19.15. Daiichi Sankyo Company
    • 19.16. Akorn Inc
    • 19.17. Pfizer Inc.
    • 19.18. Takeda Pharmaceutical Company Limited
    • 19.19. Mylan N.V.
    • 19.20. Sun Pharmaceutical Industries Ltd
    • 19.21. Tilray
    • 19.22. GW PHARMACEUTICALS PLC
    • 19.23. Aphria Incorporation
    • 19.24. Aurora Cannabis Inc
    • 19.25. Canopy Growth Corporation
    • 19.26. Insys Therapeutics, Inc.
    • 19.27. Medical Marijuana, Inc.
    • 19.28. The Peace Naturals Project
    • 19.29. CANNABIS SATIVA, INC.
    • 19.30. Green Relief Inc.
  • 20. Assumptions and Acronyms Used
  • 21. Research Methodology

List of Tables

Table 01: Pipeline Assessment for Stimulants

Table 02: Expenditure on Health, (% of GDP), by Country, 2018 to 2022

Table 03: Expenditure on Health, (% of GDP), by Country, 2018 to 2022

Table 04: Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 05: Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 06: Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 07: Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 08: Global Market size (US$ Mn) Analysis 2013 to 2017 and Forecast 2018 to 2028 By Region

Table 09: North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 10: North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 11: North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 12: North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 13: North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 14: Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 15: Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 16: Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 17: Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 18: Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 19: Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 20: Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 21: Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 22: Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 23: Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 24: East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 25: East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 26: East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 27: East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 28: East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 29: South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 30: South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 31: South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 32: South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 33: South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 34: Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 35: Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 36: Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 37: Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 38: Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 39: MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 40: MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 41: MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 42: MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 43: MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 44: Emerging Market Value Proportion Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country vs Global value

Table 45: India Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 46: India Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 47: India Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 48: India Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 49: South Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 50: South Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 51: South Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 52: South Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 53: Brazil Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 54: Brazil Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class

Table 55: Brazil Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

Table 56: Brazil Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

List of Figures

Figure 01: Pipeline Assessment For Opioids, By phase

Figure 02: Pipeline Assessment For Opioids, By Trial Status

Figure 03: Pipeline Assessment For Stimulants, By phase

Figure 04: Pipeline Assessment For Stimulants, By Trial Status

Figure 05: Medical Marijuana Patent Citations Analysis, 2018 to 2022, By Country

Figure 06: Medical Marijuana Patent Citations Analysis, from 2023 to 2033

Figure 07: Global Market Value Analysis and Forecast, 2018 to 2033 (US$ Mn)

Figure 08: Global Market Absolute $ Opportunity (US$ Mn), 2018 to 2022

Figure 09: Global Market Absolute $ Opportunity (US$ Mn), 2018 to 2033

Figure 10: Global Market Share%, by Drug Class, 2022E - Opioids

Figure 11: Global Market Share%, by Drug Class, 2022E - Stimulants

Figure 12: Global Market Share%, by Drug Class, 2022E - Depressants

Figure 13: Global Market Share%, by Drug Class, 2022E - Marijuana

Figure 14: Global Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 15: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 16: Global Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 17: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 18: Global Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 19: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 20: Global Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 21: Global Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 22: Global Market Attractiveness Analysis, By Drug Class

Figure 23: Global Market Attractiveness Analysis, By Application

Figure 24: Global Market Attractiveness Analysis, By Distribution Channel

Figure 25: Global Market Incremental Opportunity US$, by Region, 2018 to 2033

Figure 26: Market Share%, by Region, 2022E

Figure 27: Global Market Absolute Opportunity US$, by Region, 2023 to 2033

Figure 28: Market Share%, by Region, 2033F

Figure 29: Global Market Attractiveness Analysis, By Region

Figure 30: North America Market size (US$ Mn) Analysis, 2018 to 2022

Figure 31: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 32: US Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 33: US Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 34: Canada Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 35: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 36: North America Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 37: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 38: North America Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 39: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 40: North America Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 41: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 42: North America Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 43: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 44: North America Market Attractiveness Analysis, By Drug Type

Figure 45: North America Market Attractiveness Analysis, By Application

Figure 46: North America Market Attractiveness Analysis, By Distribution Channel

Figure 47: North America Market Attractiveness Analysis, By Country

Figure 48: Latin America Market size (US$ Mn) Analysis, 2018 to 2022

Figure 49: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 50: Brazil Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 51: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 52: Mexico Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 53: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 54: Rest of Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 55: Rest of Latin America Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 56: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 57: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 58: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 59: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 60: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 61: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 62: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 63: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 64: Latin America Market Attractiveness Analysis, By Drug Type

Figure 65: Latin America Market Attractiveness Analysis, By Application

Figure 66: Latin America Market Attractiveness Analysis, By Distribution Channel

Figure 67: Latin America Market Attractiveness Analysis, By Country

Figure 68: Europe Market size (US$ Mn) Analysis, 2018 to 2022

Figure 69: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 70: U.K. Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 71: U.K. Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 72: Germany Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 73: Germany Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 74: France Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 75: France Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 76: Italy Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 77: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 78: Spain Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 79: Spain Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 80: BENELUX Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 81: BENELUX Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 82: Russia Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 83: Russia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 84: Rest of Europe Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 85: Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 86: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 87: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 88: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 89: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 90: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 91: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 92: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 93: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 94: Europe Market Attractiveness Analysis, By Drug Type

Figure 95: Europe Market Attractiveness Analysis, By Application

Figure 96: Europe Market Attractiveness Analysis, By Distribution Channel

Figure 97: Europe Market Attractiveness Analysis, By Country

Figure 98: East Asia Market size (US$ Mn) Analysis, 2018 to 2022

Figure 99: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 100: China Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 101: China Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 102: Japan Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 103: Japan Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 104: South Korea Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 105: South Korea Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 106: East Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 107: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 108: East Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 109: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 110: East Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 111: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 112: East Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 113: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 114: East Asia Market Attractiveness Analysis, By Drug Type

Figure 115: East Asia Market Attractiveness Analysis, By Application

Figure 116: East Asia Market Attractiveness Analysis, By Distribution Channel

Figure 117: East Asia Market Attractiveness Analysis, By Country

Figure 118: South Asia Market size (US$ Mn) Analysis, 2018 to 2022

Figure 119: Global Donor Egg IVF Market Attractiveness Analysis by Region , 2023 to 2033

Figure 119: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 120: India Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 121: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 122: Thailand Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 123: Thailand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 124: Indonesia Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 125: Indonesia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 126: Malaysia Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 127: Malaysia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 128: Rest of South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 129: Rest of South Asia Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 130: South Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 131: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 132: South Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 133: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 134: South Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 135: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 136: South Asia Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 137: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 138: South Asia Market Attractiveness Analysis, By Drug Type

Figure 139: South Asia Market Attractiveness Analysis, By Application

Figure 140: South Asia Market Attractiveness Analysis, By Distribution Channel

Figure 141: South Asia Market Attractiveness Analysis, By Country

Figure 142: Oceania Market size (US$ Mn) Analysis, 2018 to 2022

Figure 143: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 144: Australia Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 145: Australia Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 146: New Zealand Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 147: New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 148: Oceania Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 149: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 150: Oceania Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 151: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 152: Oceania Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 153: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 154: Oceania Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 155: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 156: Oceania Market Attractiveness Analysis, By Drug Type

Figure 157: Oceania Market Attractiveness Analysis, By Application

Figure 158: Oceania Market Attractiveness Analysis, By Distribution Channel

Figure 159: Oceania Market Attractiveness Analysis, By Country

Figure 160: MEA Market size (US$ Mn) Analysis, 2018 to 2022

Figure 161: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 162: South Africa Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 163: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 164: GCC Countries Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 165: GCC Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 166: Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 167: Rest of MEA Market Size (US$ Mn) Analysis, 2018 to 2022

Figure 168: MEA Market Size (US$ Mn) Analysis, 2018 to 2022, by Opioids

Figure 169: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Opioids

Figure 170: MEA Market Size (US$ Mn) Analysis, 2018 to 2022, by Stimulants

Figure 171: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Stimulants

Figure 172: MEA Market Size (US$ Mn) Analysis, 2018 to 2022, by Depressants

Figure 173: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Depressants

Figure 174: MEA Market Size (US$ Mn) Analysis, 2018 to 2022, by Marijuana

Figure 175: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033, by Marijuana

Figure 176: MEA Market Attractiveness Analysis, By Drug Type

Figure 177: MEA Market Attractiveness Analysis, By Application

Figure 178: MEA Market Attractiveness Analysis, By Distribution Channel

Figure 179: MEA Market Attractiveness Analysis, By Country

Figure 180: Market Value Proportion Analysis, By Key Countries, 2022E

Figure 181: Global Vs. Country, Y-O-Y Growth Comparison

Figure 182: India Market size (US$ Mn) Analysis, 2018 to 2022

Figure 183: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 184: India Market Attractiveness Analysis, By Drug Class

Figure 185: India Market Attractiveness Analysis, By Application

Figure 186: India Market Attractiveness Analysis, By Distribution Channel

Figure 187: South Africa Market size (US$ Mn) Analysis, 2018 to 2022

Figure 188: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 189: South Africa Market Attractiveness Analysis, By Drug Class

Figure 190: South Africa Market Attractiveness Analysis, By Application

Figure 191: South Africa Market Attractiveness Analysis, By Distribution Channel

Figure 192: Brazil Market size (US$ Mn) Analysis, 2018 to 2022

Figure 193: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2023 to 2033

Figure 194: Brazil Market Attractiveness Analysis, By Drug Class

Figure 195: Brazil Market Attractiveness Analysis, By Application

Figure 196: Brazil Market Attractiveness Analysis, By Distribution Channel

Request a Free Sample

Controlled Substances Market

Your personal details are safe with us. Privacy Policy*